Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirlene Paul

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
JCO Clinical Cancer Informatics|February 18, 2025
Erratum: Measurement of Completeness and Timeliness of Linked Electronic Health Record Pharmacy Data for Early Detection of Nonadherence to Breast Cancer Adjuvant Endocrine TherapyChelsea McPeek, Shirlene Paul, Jordan Lieberenz, et al.
JCO Clinical Cancer Informatics|December 12, 2024
Measurement of Completeness and Timeliness of Linked Electronic Health Record Pharmacy Data for Early Detection of Nonadherence to Breast Cancer Adjuvant Endocrine TherapyChelsea McPeek, Shirlene Paul, Jordan Lieberenz, et al.
Journal of Breast Imaging|September 25, 2024
Supplemental Automated Breast US Screening in Patients With Dense Breasts: 5-Year Experience From an Academic Medical CenterShirlene Paul, Chelsea McPeek, Jordan Lieberenz, et al.
Journal of the American College of Radiology : JACR|December 14, 2022
Impact of the 2018 ACR Supplemental Screening Recommendations on MRI Eligibility in Breast Cancer SurvivorsJordan Lieberenz, Mia Levy, Rosalinda Alvarado, et al.
Annals of Surgical Oncology|July 5, 2022
Black Women Are Less Likely to Be Classified as High-Risk for Breast Cancer Using the Tyrer-Cuzick 8 ModelMelissa D Porterhouse, Shirlene Paul, Jordan L Lieberenz, et al.
Annals of Surgical Oncology|October 26, 2025
Evaluating the Gail Model: Racial Disparities in Breast Cancer Risk AssessmentMelissa Rangel, Shirlene Paul, Dipti Gupta, et al.
Annals of Surgical Oncology|November 23, 2025
ASO Visual Abstract: Evaluating the Gail Model: Racial Disparities in Breast Cancer Risk AssessmentMelissa Rangel, Shirlene Paul, Dipti Gupta, et al.
Journal of Breast Imaging|September 3, 2024
Breast Density Status Changes: Frequency, Sequence, and Practice ImplicationsCaitlin M Maloney, Shirlene Paul, Jordan L Lieberenz, et al.
Frontiers in Microbiomes|March 19, 2026
Metagenomic characterization of the tracheobronchial microbiome in lung cancerAlexis Bailey, Stephanie Hogue, Christine M Pierce, et al.
Genome Medicine|March 29, 2022
Interaction of bacterial genera associated with therapeutic response to immune checkpoint PD-1 blockade in a United States cohortRachel C Newsome, Raad Z Gharaibeh, Christine M Pierce, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
JCO Clinical Cancer Informatics|February 18, 2025
Erratum: Measurement of Completeness and Timeliness of Linked Electronic Health Record Pharmacy Data for Early Detection of Nonadherence to Breast Cancer Adjuvant Endocrine TherapyChelsea McPeek, Shirlene Paul, Jordan Lieberenz, et al.
JCO Clinical Cancer Informatics|December 12, 2024
Measurement of Completeness and Timeliness of Linked Electronic Health Record Pharmacy Data for Early Detection of Nonadherence to Breast Cancer Adjuvant Endocrine TherapyChelsea McPeek, Shirlene Paul, Jordan Lieberenz, et al.
Journal of Breast Imaging|September 25, 2024
Supplemental Automated Breast US Screening in Patients With Dense Breasts: 5-Year Experience From an Academic Medical CenterShirlene Paul, Chelsea McPeek, Jordan Lieberenz, et al.
Journal of the American College of Radiology : JACR|December 14, 2022
Impact of the 2018 ACR Supplemental Screening Recommendations on MRI Eligibility in Breast Cancer SurvivorsJordan Lieberenz, Mia Levy, Rosalinda Alvarado, et al.
Annals of Surgical Oncology|July 5, 2022
Black Women Are Less Likely to Be Classified as High-Risk for Breast Cancer Using the Tyrer-Cuzick 8 ModelMelissa D Porterhouse, Shirlene Paul, Jordan L Lieberenz, et al.
Annals of Surgical Oncology|October 26, 2025
Evaluating the Gail Model: Racial Disparities in Breast Cancer Risk AssessmentMelissa Rangel, Shirlene Paul, Dipti Gupta, et al.
Annals of Surgical Oncology|November 23, 2025
ASO Visual Abstract: Evaluating the Gail Model: Racial Disparities in Breast Cancer Risk AssessmentMelissa Rangel, Shirlene Paul, Dipti Gupta, et al.
Journal of Breast Imaging|September 3, 2024
Breast Density Status Changes: Frequency, Sequence, and Practice ImplicationsCaitlin M Maloney, Shirlene Paul, Jordan L Lieberenz, et al.
Frontiers in Microbiomes|March 19, 2026
Metagenomic characterization of the tracheobronchial microbiome in lung cancerAlexis Bailey, Stephanie Hogue, Christine M Pierce, et al.
Genome Medicine|March 29, 2022
Interaction of bacterial genera associated with therapeutic response to immune checkpoint PD-1 blockade in a United States cohortRachel C Newsome, Raad Z Gharaibeh, Christine M Pierce, et al.
Pageof 1